Current cover

Recent in Regulatory (page 1 of 37)

Facing a Recall? The FDA Offers Advice

In order for a recall to be effective, timely (and as painless as possible), it’s crucial that companies be prepared to take all necessary steps once it is initiated. The FDA is drafting a guidance to help.

CIR Conclusion: Judging Natural vs. Synthetic Safety

Several naturally derived ingredients are on the Cosmetic Ingredient Review’s (CIR's) list for consideration in 2019. This column explores how public opinion is not always in line with science, as far as what natural means. In addition, it provides CIR conclusions from December 2018.

[updated] FDA Oversight Becomes Closer to Reality for US Cosmetics

According to the bill's authors, it is supported by the leading cosmetic manufacturers and would give the FDA unprecedented authority. Editor's note: This report now includes CIR commentary.

FDA Talks Cannabis Next Steps, Announces Public Hearing

The new steps will include the creation of an eternal agency that will explore potential pathways for the lawful marketing of products with CBD.

EU Regulatory Update on Beauty and Brexit, Plus Microplastics and Nanomaterials

As the expected date for the U.K. to exit the European Union approaches, beauty brands need to act to ensure compliance post-Brexit. This Cosmetic, Toiletry and Perfumery Association update also includes insights on the EU's microplastic activity and nanomaterials catalog. Click through to read more in the digital edition.

[update] California Moves to Ban 'Harmful' Cosmetic Ingredients

Citing health concerns, the California legislature has introduced a bill that would ban several cosmetic ingredients, spanning pigments, preservatives and parabens.

[update] New Law Permits Sunscreen Use By Minors at School

The need for such legislation arose from concerned dermatologists and reports in the media of students being required to carry a note or prescription in order to possess or use sunscreen.

Croda Backs Proposed Updates to FDA Sunscreen Regulations

The proposed update would reclassify TiO2 (titanium dioxide) and ZnO (zinc oxide) as GRASE (Generally Recognized as Safe and Effective) category I. Previously, none of the 16 active ingredients currently on the market were considered GRASE.

Ned Sharpless to Serve as Acting FDA Commissioner

The announcement comes following the resignation of Scott Gottlieb, who devoted his tenure to addressing youth e-cigarette use and modernizing food safety.

[podcast] Why the FDA Disallows Europe’s Sunscreens

Between limited UV filter options and bans on organic sunscreens, the U.S. sunscreen market is wrought with strife. So why not just add Europe's UV filters to expand the U.S. portfolio? As David Steinberg explains in this podcast, it's not that easy. Listen now.

FDA Commissioner Resigns; Agency Updates 2017 Asbestos Findings

Scott Gottlieb, who assumed the role in May 2017, cited the commute from Connecticut to Washington, D.C., as motivation for his resignation. The organization also released an update on 2017 findings of asbestos in cosmetics.

Can't find what you're looking for? Try searching, or looking through past issues.